SIRT3 and Hepatic fibrosis: Moreover, SIRT3 overexpression protected hepatic function, attenuated liver fibrosis, alleviated the inflammatory response, and prevented hepatocyte apoptosis, making SIRT3 a potential therapeutic target for the treatment of nonalcoholic fatty liver disease [48].